NorthWest Biotherapeutics Inc (NWBO)

[10baggerz]

Always great to see you post doctor diver!
I think you're analysis makes a lot of sense.Was wondering if you might care to opine about a couple issues that remain unexplained:
1. Why is the MAA review taking so long and why does the MHRA keep stating that the NWBO MAA is not part of any back log (and at one point that the MAA is "with the company") 
2. Simarily, why did GZ's email keep referring to the fact that frequent interactions between NWBO and the MHRA really only started after the MHRA MAA backlog was cleared on 3/31/25?

3. Why has NWBO not submitted evidence to NICE? Could this imply that they need to wait until the Type II variation is approved before filing for NICE reimbursement (maybe this is why NWBO was listed on the NIH high cost drug list for all cancers so early, to give everyone the opportunity to get funding prior to waiting on)?